About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 345 record(s)
Req # A-2021-001976
The "sponsor" for drug submissions to Health Canada have been granted a Notice of Compliance (NOC). I would like to know if there are any drug products for human use which have been approved by Health Canada which have a sponsor that is NOT industry related. For example, I would like to obtain records for NOCs which the sponsor was an academic institution, research institute, health care facility (e.g. hospital), or any other public entity or a public-private partnership (P3).Organization: Health Canada
March 2022
Req # A-2021-001994
The number of deaths due to covid in individuals without any pre existing health conditions in Canada since 2020.Organization: Health Canada
March 2022
Req # A-2021-002010
The compliance letter issued to “Arshia Hair Salon and Spa” in 2018 (time period: Jan 1, 2018 to Dec 31, 2018). Documents showing how and when the recipient received the compliance letter.Organization: Health Canada
March 2022
Req # A-2021-002019
List of all departments, organizations, academic or research institutions, enterprises, figures, contracts or establishments otherwise not listed, that were involved or asked to take part in the Sero-Surveillance Consortium budget as found in federal government's Supplementary Estimates (A) 2021-2022. Please include all final documents between the individuals from the initial requested list and Health Canada from March 2021-October 2021, regarding the Sero-Surveillance Consortium.Organization: Health Canada
March 2022
Req # A-2021-002032
Obtain certain information regarding the status of the Health Canada file on this company: Tôle-Inox Inc. (NEQ: 1145446598), 465 Rue Saint-Jean-Baptiste Sud, Princeville, Quebec, G6L 4B7.Organization: Health Canada
March 2022
Req # A-2021-002042
All final versions of briefing materials, documents, slide decks and charts on bilingual COVID-19 public health messaging.Organization: Health Canada
March 2022
Req # A-2021-002052
All contracts signed between any/all government of Canada offices/branches, such as but not limited to Health Canada, and Pfizer International, Pfizer Canada, and or all of its subsidiaries in regards to Covid-19 vaccine purchase and roll out.Organization: Health Canada
March 2022
Req # A-2019-000420
Adverse Drug Reactions (ADRs). Report numbers: E2B-02297454, E2B-02298134, 000653339, E2B 02136648, E2B 02192932, 000718881, E2B _ 02332814.Organization: Health Canada
March 2022
Req # A-2019-001465
Adverse Drug Reactions (ADRs). Report numbers: E2B_01640410, E2B_02472710, E2B_01645694, E2B_02510112, E2B_01691225, E2B_01580047, E2B_01813301, E2B_01966315, E2B_02562614, E2B_01897383, 000703789, E2B_02599182, E2B_01862541, E2B_01664374, E2B_01802327, E2B_01806982, E2B_01645934, E2B_01857435, E2B_01790831, E2B_01707430.Organization: Health Canada
March 2022
Req # A-2019-001899
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02386339, E2B_02386626, E2B_02386590, E2B_01436862, E2B_02102951, E2B_02358592, E2B_02361162, E2B_02377196, E2B_02283676, E2B_02337047, 000723438, E2B_02399672, E2B_02315422, E2B_02327977, E2B_02322510, E2B_02315343, E2B_02326877, E2B_02318836, E2B_02317209, E2B_02316329.Organization: Health Canada
March 2022